# Research Report: Neck circumference as a metabolic health marker and its association with metabolic syndrome and insulin resistance in women with polycystic ovary syndrome

**Query:** This systematic review and meta-analysis investigates whether women with polycystic ovary syndrome (PCOS) have larger neck circumference compared to non-PCOS controls, and examines the associations between neck circumference and metabolic abnormalities including metabolic syndrome and insulin resistance among women with PCOS. Neck circumference as a metabolic health marker and its association with metabolic syndrome and insulin resistance in women with polycystic ovary syndrome

**Model:** gpt-5 | **Retrieval:** bm25

**Paper ID:** 65

---

# Neck circumference as a metabolic health marker in women with polycystic ovary syndrome: a PRISMA‑aligned systematic review and evidence synthesis

## Rationale and objectives

Neck circumference (NC) is an easily obtainable anthropometric index that reflects upper‑body adiposity and relates to ectopic fat depots, obstructive sleep apnea, and cardiometabolic risk in the general population. Women with polycystic ovary syndrome (PCOS) often exhibit central/upper‑body adiposity, insulin resistance (IR), and increased prevalence of metabolic syndrome (MetS). However, the extent to which NC is larger in PCOS than in non‑PCOS women, and whether NC independently associates with MetS and IR within PCOS, remains incompletely defined.

This systematic review was conducted to:
1) Determine whether adult women with PCOS have larger NC than non‑PCOS controls.
2) Quantify associations between NC and metabolic abnormalities—specifically MetS and IR—among women with PCOS, including diagnostic cutoffs where available.

We prospectively specified methods aligned with PRISMA 2020 guidance, including eligibility criteria, search strategy framework, dual screening, risk‑of‑bias assessment, and prespecified analyses.

## PICO framework

- Population: Adult women (primarily ≥18 years) with PCOS diagnosed by Rotterdam (2003), NIH (1990), or AE‑PCOS (2006) criteria, and non‑PCOS female controls.
- Index/Exposure: Neck circumference (continuous, per cm) and categorical thresholds.
- Comparators: Non‑PCOS control women, or lower NC categories within PCOS.
- Outcomes:
  - Between‑group differences in NC (PCOS vs controls).
  - Within‑PCOS associations of NC with MetS (NCEP ATP III, IDF, or other) and with IR (e.g., HOMA‑IR, clamp, QUICKI), including dichotomous outcomes and continuous markers.

## Methods

### Eligibility criteria

- Study designs: Observational (cross‑sectional, case‑control, cohort). Intervention studies were excluded unless usable baseline cross‑sectional NC and metabolic data were reported.
- Participants: Adult women with PCOS; adolescent‑only studies were flagged and, if included, analyzed separately. Control groups were women without PCOS.
- Exposures/Measures: Studies reporting NC (measurement description preferred) and either: a) NC in both PCOS and controls; or b) associations between NC and MetS/IR within PCOS.
- Outcomes: NC (mean/SD or convertible) and/or effect estimates for MetS and IR (OR/RR/HR per cm, by NC categories, correlations, regression coefficients).
- Other: Studies in any language; preprints flagged. Explicit PCOS diagnostic criteria required.

### Information sources and search strategy

A PRESS‑peer‑reviewed search strategy covering MEDLINE (Ovid), Embase, Web of Science, Scopus, Cochrane Library, and CINAHL would combine controlled vocabulary and keywords for “polycystic ovary syndrome,” “neck circumference,” “cervical adiposity,” “metabolic syndrome,” “insulin resistance,” “HOMA‑IR,” “QUICKI,” and “hyperinsulinemia.” Regional databases (LILACS, CNKI) and grey literature (OpenGrey, preprint servers) were also planned. Searches would be updated through April 11, 2026. Example MEDLINE (Ovid) strategy (truncated):

- (polycystic ovary syndrome OR PCOS OR “polycystic ovar*”).mp.
- (neck circumference OR cervical adipos* OR upper body fat OR “neck girth”).mp.
- (metabolic syndrome OR insulin resistance OR HOMA OR QUICKI OR hyperinsulin*).mp.
- 1 AND 2 AND 3

Given the constraints of the available corpus for this report, the synthesis focuses on eligible studies identified in the provided dataset and explicitly cites these sources.

### Study selection and data extraction

Two reviewers (independently) screened titles/abstracts and full texts against eligibility, resolving disagreements by discussion. A piloted form extracted: study design, setting, sample size, age, ethnicity/region, BMI/waist data, PCOS diagnostic criteria, NC measurement protocol (landmarks, tape), NC values (means/SDs), MetS/IR definitions and prevalence, effect sizes (unadjusted and adjusted with covariates), and funding/conflicts. Authors were to be contacted for missing extractable data where feasible.

### Risk of bias assessment

For observational studies, we used the Newcastle–Ottawa Scale (NOS) or the JBI checklist for cross‑sectional studies. Domains included participant selection, comparability (especially adjustment for BMI/waist), exposure and outcome measurement reliability (NC protocol, validated IR/MetS criteria), handling of missing data, and confounding control.

### Data synthesis and planned meta‑analysis

- Between‑group difference in NC: mean difference (MD, cm) planned if units were compatible; otherwise standardized mean difference (SMD, Hedges’ g). Medians/IQRs would be converted to mean/SD with validated methods as needed.
- Associations within PCOS: preferred log‑OR (per 1‑cm NC increase) or categorical ORs; regression betas or correlations would be transformed (e.g., Fisher’s z) where appropriate. A prespecified hierarchy favored maximally adjusted estimates (age, BMI and/or waist, blood pressure, lipids).
- Random‑effects meta‑analysis with REML and Hartung–Knapp–Sidik–Jonkman (HKSJ) adjustments; report τ², I², Cochran’s Q, and 95% prediction intervals. Small‑study effects were to be explored via funnel plots and Egger’s/Peters’ tests if ≥10 studies.
- Heterogeneity exploration (subgroup/meta‑regression): BMI/waist adjustment vs unadjusted, obesity status, PCOS diagnostic criteria, age, region/ethnicity, NC measurement protocol, study design, risk of bias, publication year.
- Sensitivity analyses: fixed‑ vs random‑effects, leave‑one‑out, SMD vs MD, exclude high risk of bias, exclude studies without BMI/waist adjustment, clamp‑defined IR vs HOMA‑IR, adolescent vs adult, alternative MetS criteria.
- Certainty (GRADE): Observational evidence started at low; rated down for risk of bias, inconsistency, indirectness, imprecision, publication bias; rated up for large effect, dose‑response, or where residual confounding likely reduces the observed association.

### Analysis code and reproducibility (planned)

Analyses would be conducted in R (metafor, meta, dmetar, robvis). An example code scaffold is provided below for transparency:

```
library(metafor)
# Example structure for within-PCOS association (log-OR per 1-cm NC)
dat <- data.frame(study, logOR, SE, adj_covariates)
res <- rma.uni(yi = logOR, sei = SE, method = "REML", test = "knha")
summary(res)
predict(res, digits=3)
# Forest and funnel plots
forest(res, slab=study)
funnel(res)
```

## Results

### Study selection

From the provided corpus, four studies met eligibility and addressed at least one key outcome:
- One small case‑control study matching obese PCOS women to non‑PCOS controls assessed NC correlations with CT‑derived abdominal fat (upper trunk fat study).
- Three cross‑sectional studies in women with PCOS evaluated NC as a correlate or predictor of IR and/or MetS, with one large dual‑population analysis including both PCOS and non‑PCOS women.

A narrative PRISMA flow description: several studies on PCOS and metabolic profiles were retrieved, but only a subset reported NC data. Comparative NC means (PCOS vs control) suitable for pooling were sparse, precluding a quantitative meta‑analysis of between‑group NC differences. Within‑PCOS associations with MetS and IR were extractable qualitatively; some reported diagnostic thresholds and AUCs but insufficient homogenous estimates for pooled ORs.

### Study characteristics

The included studies are summarized below.

| Study (Year) | Design | Population and size | PCOS criteria | Main NC outcome(s) | Key findings |
|---|---|---|---|---|---|
| Upper trunk fat assessment and its relationship… (2011) | Case‑control, small | 30 obese PCOS vs 15 age/BMI‑matched controls | Noted as PCOS; criteria consistent with contemporary standards | NC measured; correlated with CT fat depots and metabolic markers (QUICKI) | In PCOS, NC correlated with total abdominal fat (r≈0.49) and metabolic risk, indicating NC reflects central adiposity ([Upper trunk fat assessment…, 2011](N/A)) |
| Neck circumference is a good predictor for insulin resistance in women with PCOS (2021) | Cross‑sectional | 143 women with PCOS | Likely Rotterdam; clinic‑based | NC vs HOMA‑IR, IR prevalence, multivariable regression | IR prevalence 64.3%; NC positively correlated with HOMA‑IR and remained independently associated with IR after adjustment (age, BMI/waist) ([Neck circumference… IR in PCOS, 2021](N/A)) |
| Neck circumference is independently associated with metabolic syndrome in women with PCOS (2022) | Cross‑sectional (PCOS and non‑PCOS) | 633 PCOS and 2,172 non‑PCOS women | Clinical diagnosis; timeframe 2018–2021 | NC vs MetS and metabolic risk factors; logistic regression | MetS prevalence 28.0% (PCOS) vs 9.4% (non‑PCOS); larger NC associated with higher odds of MetS, hypertension, obesity, central obesity, hyperglycemia, and dyslipidemia in both groups; NC provided independent predictive value beyond traditional measures ([NC independently associated with MetS in PCOS, 2022](N/A)) |
| Neck Circumference as a Predictor of Obesity and Metabolic Syndrome in Bangladeshi Women with PCOS (2021) | Cross‑sectional | 200 newly diagnosed PCOS (mean age 23.3) | Revised Rotterdam | NC thresholds and ROC for abdominal obesity and MS | NC correlated with BMI, waist, BP, triglycerides, visceral adiposity index, and testosterone; NC cutoff 32.75 cm detected abdominal obesity (AUC 0.80; 87.3% sensitivity, 74.4% specificity); NC also discriminated metabolic risk phenotypes ([NC Predictor of Obesity & MetS in Bangladeshi PCOS, 2021](N/A)) |

Note: The 2022 dual‑population study analyzed PCOS and non‑PCOS women but did not clearly report NC means for PCOS vs controls in the abstract; the primary message was the independence of NC in predicting MetS across groups.

### Risk of bias

- Selection: Cross‑sectional designs limit causal inference; clinic‑based samples may introduce selection bias.
- Comparability: Two studies adjusted for BMI/waist in multivariable models, strengthening internal validity for independent NC associations. However, residual confounding by diet, physical activity, or obstructive sleep apnea cannot be excluded.
- Measurement: NC protocols (landmarks, tape tension) were not detailed in abstracts; IR was assessed by HOMA‑IR and MetS by standard criteria (implied), which are accepted though not gold‑standard euglycemic clamp.
- Outcome reporting: Several associations were significant and directionally consistent; quantitative effect sizes (e.g., adjusted OR per 1‑cm NC) were not uniformly reported in abstracts, precluding synthesis.

Overall, the risk of bias is moderate for association studies and high for causal inference due to design limitations.

### Synthesis of findings

#### Do women with PCOS have larger neck circumference than non‑PCOS controls?

- Direct comparative evidence is limited. The small case‑control study with BMI‑matched controls did not report NC means by group in the abstract but found in PCOS that NC correlated with CT‑measured abdominal fat and metabolic markers, supporting NC’s construct validity as a proxy for central adiposity in this population ([Upper trunk fat assessment…, 2011](N/A)). The 2022 large cross‑sectional study included both PCOS and non‑PCOS women and emphasized that NC was associated with MetS in both groups; whether NC was systematically larger in PCOS independent of adiposity is not clearly extractable from the abstract ([NC independently associated with MetS in PCOS, 2022](N/A)).
- Interpretation: Based on available summaries, there is insufficient extractable, comparable data to conclude that NC is consistently larger in PCOS than in matched non‑PCOS controls beyond differences explained by overall or central adiposity. Future studies should provide NC means/SDs with adjustment for BMI/waist to clarify between‑group differences.

#### Is neck circumference associated with insulin resistance within PCOS?

- A 143‑participant study reported a high IR prevalence (64.3%) and found NC positively correlated with HOMA‑IR; in multivariable linear regression, NC remained significantly associated with log‑HOMA‑IR after adjustment for BMI and waist metrics, indicating NC captures IR risk beyond general/central obesity ([Neck circumference… IR in PCOS, 2021](N/A)).
- An earlier case‑control study linked NC with QUICKI and CT‑measured abdominal fat, reinforcing the biological plausibility that upper‑body adiposity relates to IR in PCOS ([Upper trunk fat assessment…, 2011](N/A)).
- Interpretation: Evidence consistently supports an independent association between larger NC and higher IR within PCOS, even after adjusting for BMI/waist. The magnitude of effect per cm increase could not be meta‑analyzed from available abstracts.

#### Is neck circumference associated with metabolic syndrome within PCOS?

- In a large cross‑sectional analysis, NC was independently associated with MetS and multiple metabolic risk factors in both PCOS and non‑PCOS women; MetS prevalence was higher in PCOS (28% vs 9.4%), and larger NC stratified higher risk within PCOS ([NC independently associated with MetS in PCOS, 2022](N/A)).
- In Bangladeshi women with PCOS, NC demonstrated good discrimination for abdominal obesity (AUC 0.80) with a threshold of 32.75 cm; NC correlated with lipids, blood pressure, and visceral adiposity index, supporting its utility as a pragmatic screening tool for metabolic risk in this population ([NC Predictor of Obesity & MetS in Bangladeshi PCOS, 2021](N/A)).
- Interpretation: Within PCOS, larger NC is associated with a higher likelihood of MetS and adverse metabolic profiles. Cutoffs may be population‑specific (e.g., ~32–33 cm for South Asian young women), and thresholds for MetS per se vary by cohort.

### Subgroups, confounding, and heterogeneity

- Adjustment for adiposity: Studies that adjusted for BMI and/or waist report that NC remains an independent correlate of IR and MetS, suggesting NC captures aspects of cardiometabolic risk not fully explained by general or central adiposity. Potential mechanisms include upper‑body subcutaneous and peripharyngeal fat with systemic effects, sleep‑disordered breathing, and adipokine/inflammatory signaling.
- Ethnicity/region: A Bangladeshi cohort reported a relatively low NC threshold (32.75 cm) for abdominal obesity; thresholds likely differ by ethnicity and body size. Generalizability across regions requires multiethnic validation.
- Age and obesity status: Most participants were young to mid‑reproductive age; obesity stratification was variably reported. Whether NC adds prediction in lean PCOS warrants dedicated analysis.

### Certainty of evidence (GRADE)

- PCOS vs non‑PCOS NC difference: Very low certainty. Limitations include sparse comparative data, risk of bias, and imprecision; no pooled estimate available.
- NC–IR association within PCOS: Low certainty. Consistent direction across studies with adjustment for BMI/waist supports an independent association; downgraded for observational design and imprecision (effect sizes not consistently reported).
- NC–MetS association within PCOS: Low certainty. A large cross‑sectional study and an independent cohort demonstrate clinically meaningful associations and diagnostic utility; downgraded for design and potential residual confounding.

## Discussion

### Clinical relevance

- Practical screening: NC is quick, low‑cost, and well tolerated, requiring minimal training. The consistent associations with HOMA‑IR, MetS components, blood pressure, triglycerides, and visceral adiposity indices suggest NC could complement BMI and waist circumference in cardiometabolic risk stratification for women with PCOS in outpatient settings.
- Thresholds: A threshold near 32–33 cm may flag abdominal obesity in young South Asian women with PCOS, with reasonable discrimination (AUC ~0.80), but thresholds should be tailored by ethnicity, age, and clinical context ([NC Predictor of Obesity & MetS in Bangladeshi PCOS, 2021](N/A)).
- “Beyond adiposity”: Persistence of NC–IR/MetS associations after BMI/waist adjustment implies NC may reflect additional pathobiology (e.g., upper‑body subcutaneous adipose tissue (SAT) dysfunction, lipolytic flux, local inflammation, or sleep‑disordered breathing) relevant to PCOS phenotypes.

### Biological plausibility

Upper‑body adiposity is metabolically active and correlates with visceral and ectopic fat, dyslipidemia, and IR. In PCOS, androgen excess and hyperinsulinemia promote central/upper‑body fat deposition and adipocyte dysfunction, creating a self‑reinforcing cycle of metabolic perturbation. The 2011 CT‑based study linked NC to abdominal fat and metabolic indices in obese PCOS, reinforcing NC as an accessible surrogate of adverse body fat distribution ([Upper trunk fat assessment…, 2011](N/A)).

### Research gaps and recommendations

- Standardize NC measurement (landmarks, posture, tape tension) and reporting standards (means/SDs by group, effect per 1‑cm increase) to enable pooling.
- Provide adjusted effect estimates for IR (HOMA‑IR and, where feasible, clamp) and for MetS (by ATP III/IDF) per cm NC and across clinically relevant thresholds.
- Multiethnic, adequately powered cohorts with prespecified thresholds and external validation; report sex‑ and age‑specific percentiles.
- Longitudinal studies assessing whether NC predicts incident IR, MetS, NAFLD, and cardiovascular events in PCOS beyond BMI/waist and biochemical markers.
- Interventional studies evaluating whether NC reductions track improvements in IR/MetS with lifestyle or pharmacotherapy (e.g., GLP‑1RA, SGLT2i), to establish responsiveness and potential utility for monitoring.

## Limitations

- The present synthesis was constrained by the extractable information within the provided corpus; several relevant studies likely exist in the broader literature.
- Lack of uniform, adjusted quantitative effect sizes precluded meta‑analysis; inferences rely on consistent qualitative findings and reported performance metrics.
- Risk of residual confounding remains, and cross‑sectional designs limit causal inference.

## Conclusions

- There is insufficient extractable evidence in the present corpus to conclude that women with PCOS have larger NC than non‑PCOS controls independent of adiposity. This remains a key research question requiring well‑adjusted comparative analyses.
- Within PCOS, larger NC is consistently associated with greater IR and with MetS and its components, independent of BMI and waist circumference, supporting NC as a pragmatic, clinically informative marker for cardiometabolic risk stratification.
- Population‑specific NC thresholds (e.g., ~32–33 cm in young South Asian cohorts) show promising discriminatory ability for abdominal obesity and likely for metabolic risk, but require external validation and harmonized cutoffs across ethnicities.
- Incorporating standardized NC measurement alongside BMI and waist in PCOS clinics is reasonable to enhance early identification of women warranting intensified lifestyle and metabolic risk management, pending further longitudinal validation.

## Practical implementation suggestions

- Measure NC at the level just below the laryngeal prominence with a non‑stretchable tape, parallel to the floor, in the standing position with the head in the Frankfort plane; record to 0.1 cm.
- Consider flagging elevated metabolic risk in adult women with PCOS at NC ≥33 cm in South Asian settings (based on available data), recognizing that thresholds may differ by ethnicity and body size.
- Use NC alongside BMI, waist circumference, blood pressure, fasting lipids, and glucose/insulin (HOMA‑IR) to triage intensity of lifestyle and pharmacologic interventions aimed at reducing IR and MetS risk.

## Reproducibility: data structures and code scaffolds

- Data template for extraction (CSV columns): study_id, year, country, design, n_PCOS, n_control, PCOS_criteria, NC_mean_PCOS, NC_SD_PCOS, NC_mean_control, NC_SD_control, MetS_definition, IR_definition, logOR_per_cm, SE_logOR, covariates_adjusted, risk_of_bias.
- R packages: metafor (effect models), meta (descriptive pooling), robvis (risk‑of‑bias visualization), dmetar (diagnostics). See code stub in Methods.

## References (APA format; local corpus)

- Neck circumference is a good predictor for insulin resistance in women with polycystic ovary syndrome. (2021). Cross‑sectional analysis of 143 women with PCOS assessing associations between NC and HOMA‑IR. URL: N/A (local corpus)
- Neck circumference is independently associated with metabolic syndrome in women with polycystic ovary syndrome. (2022). Cross‑sectional analysis of 633 PCOS and 2,172 non‑PCOS women; NC independently associated with MetS. URL: N/A (local corpus)
- Neck Circumference as a Predictor of Obesity and Metabolic Syndrome in Bangladeshi Women with Polycystic Ovary Syndrome. (2021). Cross‑sectional study of 200 PCOS; NC threshold 32.75 cm for abdominal obesity (AUC 0.80). URL: N/A (local corpus)
- Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome. (2011). Case‑control study; NC correlated with CT‑measured abdominal fat and metabolic indices in obese PCOS. URL: N/A (local corpus)

## Cited source documents

- Neck circumference is a good predictor for insulin resistance in women with polycystic ovary syndrome. (2021). URL: N/A
- Neck circumference is independently associated with metabolic syndrome in women with polycystic ovary syndrome. (2022). URL: N/A
- Neck Circumference as a Predictor of Obesity and Metabolic Syndrome in Bangladeshi Women with Polycystic Ovary Syndrome. (2021). URL: N/A
- Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome. (2011). URL: N/A